{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:37:24Z","timestamp":1792301844200,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.dsx.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T20:46:57Z","timestamp":1586465217000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":618,"title":["Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8374-4536","authenticated-orcid":false,"given":"Awadhesh Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amerta","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2020.04.004_bib1","unstructured":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 73 https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_2"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.004_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.dsx.2020.03.002","article-title":"Clinical considerations for patients with diabetes in times of COVID-19 epidemic","volume":"14","author":"Gupta","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2020.04.004_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s005920170017","article-title":"Bacterial pneumonia: comparison between diabetics and non-dia-betics","volume":"38","author":"Akbar","year":"2001","journal-title":"Acta Diabetol"},{"issue":"6","key":"10.1016\/j.dsx.2020.04.004_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet Med"},{"issue":"7","key":"10.1016\/j.dsx.2020.04.004_bib5","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2337\/dc09-2215","article-title":"Diabetes and the severity of pandemic influenza A (H1N1) infection","volume":"33","author":"Allard","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2020.04.004_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","article-title":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","volume":"49","author":"Badawi","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.dsx.2020.04.004_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/cid\/ciu226","article-title":"Middle East respiratory syndrome coronavirus: a case\u2013control study of hospitalized patients","volume":"59","author":"Al-Tawfiq","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.dsx.2020.04.004_bib8","first-page":"49","article-title":"Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans","volume":"22","author":"Alraddadi","year":"2016","journal-title":"Saudi Arabia 2014 Emerg Infect Dis"},{"key":"10.1016\/j.dsx.2020.04.004_bib9","article-title":"Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers","author":"Singh","year":"2020","journal-title":"Diabetes Metabol Syndrome Res Rev"},{"key":"10.1016\/j.dsx.2020.04.004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.004_bib11","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","volume":"41","author":"Epidemiology Working Group for Ncip Epidemic Response","year":"2020","journal-title":"Chin J Epidemiol"},{"key":"10.1016\/j.dsx.2020.04.004_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","author":"Onder","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2020.04.004_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically ill patients in the seattle region \u2014 case series","author":"Bhatraju","year":"2020","journal-title":"NEJM.org"},{"key":"10.1016\/j.dsx.2020.04.004_bib14","author":"Covid-19 surveillance group, Italy"},{"key":"10.1016\/j.dsx.2020.04.004_bib16","author":"Liu"},{"key":"10.1016\/j.dsx.2020.04.004_bib17","author":"Guan"},{"issue":"10223","key":"10.1016\/j.dsx.2020.04.004_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2020.04.004_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.dsx.2020.04.004_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2020.04.004_bib21","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"9","author":"Zhou","year":"2020","journal-title":"Published Online March"},{"key":"10.1016\/j.dsx.2020.04.004_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARSCoV-2 in Wuhan, China","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.dsx.2020.04.004_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.dsx.2020.04.004_bib24","doi-asserted-by":"crossref","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et\u00a0al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China. JAMA Intern Med. Published online March 13, 2020. doi:10.1001\/jamainternmed.2020.0994 (Accessed on March 31, 2020)","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"10.1016\/j.dsx.2020.04.004_bib25","doi-asserted-by":"crossref","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et\u00a0al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. doi:10.1001\/jamacardio.2020.1017. Published online March 31, 2020.","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"10.1016\/j.dsx.2020.04.004_bib26","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","author":"Liu","year":"2020","journal-title":"Chin Med J"},{"key":"10.1016\/j.dsx.2020.04.004_bib27","first-page":"m109","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.dsx.2020.04.004_bib28","author":"Chen"},{"key":"10.1016\/j.dsx.2020.04.004_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u00a0314 cases from the Chinese center for disease control and prevention","author":"Wu","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2020.04.004_bib30","author":"Wang"},{"key":"10.1016\/j.dsx.2020.04.004_bib31","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with covid-19","author":"Vaduganathan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2020.04.004_bib32","first-page":"2020","article-title":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells","author":"Hoffmann","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.dsx.2020.04.004_bib33","first-page":"2020","article-title":"Hypertension and diabetes delay the viral clearance in COVID-19 patients","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.dsx.2020.04.004_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030563","article-title":"Characterization of ACE and ACE2 287 expression within different organs of the NOD mouse","volume":"18","author":"Roca-Ho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dsx.2020.04.004_bib35","doi-asserted-by":"crossref","unstructured":"Rao S, Lau A, and So H-C. Exploring diseases\/traits and blood proteins causally related to 284 expression of ACE2, the putative receptor of 2019-nCov: a Mendelian Randomization analysis. vol. 285 medRxiv: 2020.2003.2004.20031237, 2020.","DOI":"10.2337\/figshare.12279131.v1"},{"key":"10.1016\/j.dsx.2020.04.004_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/joim.12783","article-title":"Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality","volume":"284","author":"Fernandez","year":"2018","journal-title":"J\u00a0Intern Med"},{"issue":"20","key":"10.1016\/j.dsx.2020.04.004_bib37","doi-asserted-by":"crossref","first-page":"131774","DOI":"10.1172\/jci.insight.131774","article-title":"Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection","volume":"4","author":"Kulcsar","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.dsx.2020.04.004_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3321","article-title":"Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics","author":"Maddaloni","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.dsx.2020.04.004_bib39","series-title":"A\u00a0multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)","year":"2020"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.004_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.004_bib41","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4049\/jimmunol.1700474","article-title":"Metformin mediates protection against Legionella pneumonia through activation of AMPK and mitochondrial reactive oxygen species","volume":"200","author":"Kajiwara","year":"2018","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.004_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00228-019-02786-y","article-title":"Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis","volume":"76","author":"Zhang","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.dsx.2020.04.004_bib43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/resp.13486","article-title":"Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin","volume":"24","author":"Mendy","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.dsx.2020.04.004_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12931-019-1035-9","article-title":"Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease","volume":"20","author":"Ho","year":"2019","journal-title":"Respir Res"},{"issue":"9","key":"10.1016\/j.dsx.2020.04.004_bib45","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/bcp.13288","article-title":"Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study","volume":"83","author":"Gorricho","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dsx.2020.04.004_bib46","first-page":"603409","article-title":"Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis","volume":"2014","author":"Zhang","year":"2014","journal-title":"Sci World J"},{"issue":"10","key":"10.1016\/j.dsx.2020.04.004_bib47","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1210\/en.2014-1685","article-title":"Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats","volume":"156","author":"Roman\u00ed-P\u00e9rez","year":"2015","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.dsx.2020.04.004_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00089-0","article-title":"Dipeptidyl-peptidase IV (CD26)\u2013role in the inactivation of regulatory peptides","volume":"85","author":"Mentlein","year":"1999","journal-title":"Regul Pept"},{"issue":"10","key":"10.1016\/j.dsx.2020.04.004_bib49","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.00128-13","article-title":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies","volume":"87","author":"Gierer","year":"2013","journal-title":"J\u00a0Virol"},{"issue":"10","key":"10.1016\/j.dsx.2020.04.004_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076469","article-title":"Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation","volume":"8","author":"Qian","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.dsx.2020.04.004_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/22221751.2020.1713705","article-title":"Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus","volume":"9","author":"Kleine-Weber","year":"2020","journal-title":"Emerg Microb Infect"},{"issue":"7440","key":"10.1016\/j.dsx.2020.04.004_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.dsx.2020.04.004_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.dsx.2020.04.004_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1440-1681.2007.04737.x","article-title":"Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure","volume":"35","author":"Jackson","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.dsx.2020.04.004_bib55","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/HYPERTENSIONAHA.110.156554","article-title":"Interactive hemodynamic effects of dipeptidyl peptidase-IV inhibition and angiotensin-converting enzyme inhibition in humans","volume":"56","author":"Marney","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.dsx.2020.04.004_bib56","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/HYPERTENSIONAHA.113.02767","article-title":"Substance P increases sympathetic activity during combined angiotensin converting enzyme and dipeptidyl peptidase-4 inhibition","volume":"63","author":"Devin","year":"2014","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.004_bib57","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/HYPERTENSIONAHA.109.134197","article-title":"DPP-4 inhibitors use associated with increased risk of ACE-inhibitors associated angioedema","volume":"54","author":"Brown","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.dsx.2020.04.004_bib58","doi-asserted-by":"crossref","first-page":"172638","DOI":"10.1016\/j.ejphar.2019.172638","article-title":"Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme","volume":"862","author":"Abouelkheir","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dsx.2020.04.004_bib59","doi-asserted-by":"crossref","first-page":"108125","DOI":"10.1016\/j.diabres.2020.108125","article-title":"COVID-19 and Diabetes: can DPP4 inhibition play a role?","author":"Iacobellis","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.dsx.2020.04.004_bib60","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.004_bib61","first-page":"733","article-title":"Prevalence of diabetes in the 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus: a systematic review and meta-analysis","volume":"5","author":"Badawi","year":"2016","journal-title":"J\u00a0Public Health Res"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.004_bib62","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12020-018-1635-z","article-title":"Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients","volume":"61","author":"Razavi","year":"2018","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/j.dsx.2020.04.004_bib63","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1177\/1060028019841363","article-title":"Intravenous insulin infusion protocol compared with subcutaneous insulin for the management of hyperglycemia in critically ill adults","volume":"53","author":"Tran","year":"2019","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.004_bib64","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/ijccm.IJCCM_273_17","article-title":"Comparison of glycemic control between continuous regular insulin infusion and single-dose subcutaneous insulin glargine injection in medical critically ill patients","volume":"22","author":"Bhurayanontachai","year":"2018","journal-title":"Indian J Crit Care Med"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.004_bib65","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00002727-200404000-00009","article-title":"Current perspectives on the use of continuous subcutaneous insulin infusion in the acute care setting and overview of therapy","volume":"27","author":"Lee","year":"2004","journal-title":"Crit Care Nurs Q"},{"issue":"4","key":"10.1016\/j.dsx.2020.04.004_bib66","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/cc12838","article-title":"Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial","volume":"17","author":"Leelarathna","year":"2013","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.dsx.2020.04.004_bib67","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/1932296817697329","article-title":"Continuous glucose monitor interference with commonly prescribed medications: a pilot study","volume":"11","author":"Basu","year":"2017","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.004_bib68","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/TA.0000000000000127","article-title":"Continuous glucose monitoring in the surgical intensive care unit: concordance with capillary glucose","volume":"76","author":"Schuster","year":"2014","journal-title":"J\u00a0Trauma Acute Care Surg"},{"key":"10.1016\/j.dsx.2020.04.004_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system:physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dsx.2020.04.004_bib70","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1038\/srep07027","article-title":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury","volume":"4","author":"Yang","year":"2014","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.dsx.2020.04.004_bib71","first-page":"419","article-title":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia","volume":"31","author":"Henry","year":"2018","journal-title":"SAVE Proc"},{"key":"10.1016\/j.dsx.2020.04.004_bib72","article-title":"Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV","volume":"48","author":"Peng","year":"2020","journal-title":"Zhonghua Xinxueguanbing Zazhi"},{"key":"10.1016\/j.dsx.2020.04.004_bib73","series-title":"Position statement of the ESC Council on hypertension on ACE-inhibitors and angiotensin receptor blockers","year":"2020"},{"issue":"8","key":"10.1016\/j.dsx.2020.04.004_bib76","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11908-017-0581-x","article-title":"The use of statins and risk of community-acquired pneumonia","volume":"19","author":"Batais","year":"2017","journal-title":"Curr Infect Dis Rep"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.004_bib77","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00398-20","article-title":"Hiding in plain sight: an approach to treating patients with severe COVID-19 infection","volume":"11","author":"Fedson","year":"2020","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.dsx.2020.04.004_bib78","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01120-15","article-title":"Statins may decrease the fatality rate of Middle East respiratory syndrome infection","volume":"6","author":"Yuan","year":"2015","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.dsx.2020.04.004_bib79","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/MJT.0000000000000312","article-title":"Preadmission use of calcium channel blockers and outcomes after hospitalization with pneumonia: a retrospective propensity-matched cohort study","volume":"24","author":"Zheng","year":"2017","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.dsx.2020.04.004_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.dsx.2020.04.004_bib81","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2003539","article-title":"Virtually perfect? Telemedicine for covid-19","author":"Hollander","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2020.04.004_bib82","article-title":"All Feet on Deck-The Role of Podiatry during the COVID-19 Pandemic: preventing hospitalizations in an overburdened healthcare system, reducing amputation and death in people with diabetes","author":"Rogers","year":"2020","journal-title":"J\u00a0Am Podiatr Med Assoc"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120300631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120300631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:10:15Z","timestamp":1761729015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120300631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1871402120300631"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2020.04.004","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}